| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Strongbridge Biopharma plc | Chief Commercial Officer | Ordinary Shares | 0 | $2.06 | 05 Oct 2021 | Direct | |
| Strongbridge Biopharma plc | Chief Commercial Officer | Stock Option (Right to Buy) | 0 | 05 Oct 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000117911021009285-wilhoit-scott-l-2021-10-05 | Strongbridge Biopharma plc | 05 Oct 2021 | 2 | $0 | 4 | Chief Commercial Officer | 06 Oct 2021, 19:43 |
| /report/000117911021009231-wilhoit-scott-l-2021-10-01 | Strongbridge Biopharma plc | 01 Oct 2021 | 1 | -$56,681 | 4 | Chief Commercial Officer | 05 Oct 2021, 19:28 |